<ARTICLE> 5 <LEGEND> This schedule contains summary financial information extracted from Urologix FDS for 3rd Quarter Form 10-Q and is qualified in its entirety by reference to such financial statements. </LEGEND> <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> JUN-30-1997 <PERIOD-START> JUL-01-1996 <PERIOD-END> MAR-31-1997 <CASH> 697,349 <SECURITIES> 29,484,308 <RECEIVABLES> 1,528,055 <ALLOWANCES> 0 <INVENTORY> 1,712,039 <CURRENT-ASSETS> 33,702,400 <PP&E> 1,910,858 <DEPRECIATION> 582,336 <TOTAL-ASSETS> 38,186,735 <CURRENT-LIABILITIES> 2,901,434 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 91,737 <OTHER-SE> 35,149,553 <TOTAL-LIABILITY-AND-EQUITY> 38,186,735 <SALES> 1,789,500 <TOTAL-REVENUES> 1,789,500 <CGS> 1,524,123 <TOTAL-COSTS> 1,524,123 <OTHER-EXPENSES> 2,553,226 <LOSS-PROVISION> 2,287,849 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> (1,869,766) <INCOME-TAX> 0 <INCOME-CONTINUING> (1,869,766) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (1,869,766) <EPS-PRIMARY> (0.20) <EPS-DILUTED> (0.20)